SlideShare une entreprise Scribd logo
1  sur  5
Télécharger pour lire hors ligne
1
Anna King
CSU ID# 829672579
FSHN 450; Fall Semester 2014
Case Study VI: Hemodialysis & Renal Diet Calculation
November 5, 2014
I have not given, received, or used any unauthorized assistance on this assignment.
Anna King 11/5/2014
2
In table format, evaluate the patient’s laboratory data compared to goals for dialysis patients.
Value Patient’s Value Dialysis patient Goal
Sodium 135 mEq/L 135-145 mEq/L
Potassium 4.4 mEq/L 3.5-5.5 mEq/L
Chloride 111 mEq/L 100-110mEq/L
CO 2 15 mEq/L 22-25 mEq/L
Calcium 7.5 mg/dl 8.5-10.5 mg/dl
Phos 10.2 mg/dl 3-6 mg/dl
BUN 108 mg/dl 50-100 mg/dl
Creatinine 14.0 mg/dl >15 mg/dl
Albumin 2.8 g/dl 3.5-5 g/dl
Hemoglobin 8.3 g/dl 7.4-9.9 g/dl
Hct 24.3% 35-47%
Transferrin Sat 18% 15-50%
MCV 70 fl 80-99 fl
WBC 8.7 X 109
/L 5-10 x 109
/L
Urine protein 320 mg/24 hr 3-6 g/24 hr
What is the purpose of each medication which has been prescribed for the patient? List
drug:nutrient (food:medication) interactions for each.
Lasix: increases excretion of sodium, potassium, magnesium, and calcium in urine-
natural licorice may counteract the drug; maintain diet high in these compounds (may
need supplementation)
Lisinopril: ACE inhibitor, increases serum potassium levels-monitor hydration and fluid
intake as well as salt and potassium intake (may be sensitive to potassium levels)
3
Metoprolol: 𝛽-Adrenergic antagonist masks sympathetic signs of hypoglycemia-may
decrease insulin release (in response to hypoglycemia), watch BG levels
Renvela: phosphate binder (controls phosphate levels)- be careful with calcium
supplements to prevent secondary hyperparathyroidism
Zemplar: helps absorb calcium and helps with secondary hyperthyroidism- problems if
allergic to man-made vitamin D or if there are high levels of calcium in the blood
EPO: attends to anemia in patients- monitor iron status in patient!
Ferrlecit: helps with anemia- may cause hypotension, excessive iron, and benzyl alcohol
toxicity
What is secondary hyperparathyroidism and why is this patient at risk? What are the
consequences and how is this managed medically? Nutritionally?
Secondary hyperthyroidism is a result of kidney malfunction/failure. When the patient’s
kidney cannot filter minerals (in the case of secondary hyperparathyroidism, calcium and
phosphorous, specifically) out of the blood properly, their levels shoot out of proportion.
Generally, in the body, low levels of phosphorous and calcium in the blood are ideal. In
secondary hyperparathyroidism, serum calcium levels are low while serum phosphorous
increases; this triggers the parathyroid hormone to increase, which then, in turn, increases
reabsorption of calcium. Since calcium levels are already low, the body takes calcium
from bones of the body; this also mobilizes phosphorous from the bone. Increased levels
of calcium and phosphorous from the bone, now in the bloodstream don’t necessarily
have anywhere to go, so they form crystals in the tissues of the body.
The patient is at risk of secondary hyperparathyroidism because she is in Stage 5 (the
final stage) of chronic kidney failure. This is irreversible and she has to depend on
dialysis for the rest of her life. Since her kidney cannot filter minerals properly, she is
definitively at risk for secondary hyperparathyroidism.
This condition is managed medically by frequent hemodialysis and is managed
nutritionally by controlling intake of calcium and phosphorous.
Assess the patient’s Kcal, protein, Phos, K, Na, and fluid intake recommendations.
Kcal: 2061 kcal (35 kcal/Kg IBW) IBW=105+(5 x 5)=130lbs=58.9Kg
4
Protein: 71g (1.2 g/Kg IBW)
Phos: 0.8-1.2 g/day
K: 2-3 g/day
Na: 2-3 g/day
Fluid: 750 ml (750-1000 ml/day urine output)
Evaluate the patient’s current dietary intake including the following points:
How does CN’s current intake compare to these recommendations?
Some of the patient’s food is high in phosphorous, which she should monitor more
closely. Although adequate calcium intake is required, she should be more careful when
consuming foods.
Calculate a dietary pattern which would meet the recommendations for this patient and using
foods create a sample one day diet. Use table format and the handouts provided in class. This
part counts as your renal diet calculation in addition to your case study.
Protein: 17% of Kcal= 350 Kcal
Fat: <30% of Kcal= 618 Kcal
Carbohydrate: 53% of Kcal= 1092 Kcal
Carb Protein Fat Na (mg) K (mg) P (mg)
1 cup milk 6 4 - 60 190 115
Fruit- Low K: pineapple (½ cup) 15 - - 15 100 15
Fruit- Med K: apple (1) 15 - - 15 200 15
Fruit- High K: kiwi (1) 15 - - 15 350 15
Veg- Low K: corn (½ cup) 5 2 - 15 100 20
Veg- Med K: peppers (1) 5 2 - 15 200 20
Veg- High K: sweet yam (½ cup) 5 2 - 15 350 20
Bread 209 17.5 40 35 500 450
SF Meat - 60 29 75 75 65
Reg Fat - - - 10 10 5
5
Totals:
1100+350+621=2061 Kcal/day
(275x4)
= 1100
(87.5x4)
= 350
(69x9
)=621
270 2075 740
Write two PES statements - one in the clinical and one in the behavioral domain and provide an
intervention, monitoring, and evaluation plan for each.
(1) Altered GI function [NC-1.4] related to abnormal absorption of calcium and phosphorous
as evidence by kidney failure and hemodialysis.
(2) Self monitoring deficit [NB-1.4] related to insufficient diet as evidence by 24 hour
dietary intake log and medication needs.
Intervention:
(1) Take prescribed medications, monitor dietary choices (maintain low potassium and
phosphorous levels in diet).
(2) Watch diet! Educate patient on what to eat and what to avoid (avoid nuts and legumes,
eat plenty of fruits and vegetables!) and show her how her diet and the foods she chooses
affect her body physically.
Monitoring/Evaluation:
(1) Watch lab results on all values listed above, test urine samples to keep patient on track;
hemodialysis every 2-3 days; monitor GI functioning.
(2) . Monitor medication intake and make sure dosages and utilizations are correct.

Contenu connexe

Tendances

FSHN 450 liver disease case study
FSHN 450 liver disease case studyFSHN 450 liver disease case study
FSHN 450 liver disease case studyAnya Guy
 
Calcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in PregnancyCalcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in PregnancySujoy Dasgupta
 
Introduction to clinical nutrition
Introduction to clinical nutritionIntroduction to clinical nutrition
Introduction to clinical nutritionDr Iyan Darmawan
 
Diabetes 1 Case Study
Diabetes 1 Case StudyDiabetes 1 Case Study
Diabetes 1 Case StudyAlysse Milano
 
3. Complications of parenteral nutrition
3. Complications of parenteral nutrition3. Complications of parenteral nutrition
3. Complications of parenteral nutritionChartwellPA
 
Liver Disease Case Study
Liver Disease Case StudyLiver Disease Case Study
Liver Disease Case StudySonja Silva
 
Diet and gastrointestinal problems
Diet and gastrointestinal problemsDiet and gastrointestinal problems
Diet and gastrointestinal problemsmohammead osman
 
Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.Raaz Eve Mishra
 
MedReg+1 Matthews Gastro
MedReg+1 Matthews GastroMedReg+1 Matthews Gastro
MedReg+1 Matthews GastroMedReg+1
 
Diabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyDiabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyLyndon Woytuck
 
DIABETES KETOACIDOSIS CASE PRESENTATION
DIABETES KETOACIDOSIS CASE PRESENTATIONDIABETES KETOACIDOSIS CASE PRESENTATION
DIABETES KETOACIDOSIS CASE PRESENTATIONKiran Reddy
 
Severe Acute Malnutrition
Severe Acute MalnutritionSevere Acute Malnutrition
Severe Acute MalnutritionBibhu Sahu
 
Diabetes challenging cases
Diabetes challenging casesDiabetes challenging cases
Diabetes challenging casesangel4567
 
CS9CD_Gutierrez_Hill_Leslie_Marsh_Final
CS9CD_Gutierrez_Hill_Leslie_Marsh_FinalCS9CD_Gutierrez_Hill_Leslie_Marsh_Final
CS9CD_Gutierrez_Hill_Leslie_Marsh_FinalLaurie Hill
 
1.What is tpn and who needs it
1.What is tpn and who needs it1.What is tpn and who needs it
1.What is tpn and who needs itChartwellPA
 

Tendances (20)

FSHN 450 liver disease case study
FSHN 450 liver disease case studyFSHN 450 liver disease case study
FSHN 450 liver disease case study
 
Calcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in PregnancyCalcium and Vitamin D Supplementation in Pregnancy
Calcium and Vitamin D Supplementation in Pregnancy
 
Introduction to clinical nutrition
Introduction to clinical nutritionIntroduction to clinical nutrition
Introduction to clinical nutrition
 
Diabetes 1 Case Study
Diabetes 1 Case StudyDiabetes 1 Case Study
Diabetes 1 Case Study
 
3. Complications of parenteral nutrition
3. Complications of parenteral nutrition3. Complications of parenteral nutrition
3. Complications of parenteral nutrition
 
Liver Disease Case Study
Liver Disease Case StudyLiver Disease Case Study
Liver Disease Case Study
 
Diet and gastrointestinal problems
Diet and gastrointestinal problemsDiet and gastrointestinal problems
Diet and gastrointestinal problems
 
Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.Diabetes mellitus in Dogs.
Diabetes mellitus in Dogs.
 
MedReg+1 Matthews Gastro
MedReg+1 Matthews GastroMedReg+1 Matthews Gastro
MedReg+1 Matthews Gastro
 
Diabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case studyDiabetic ketoacidosis: a case study
Diabetic ketoacidosis: a case study
 
Diabetic1
Diabetic1Diabetic1
Diabetic1
 
Diabetes case-study
Diabetes case-studyDiabetes case-study
Diabetes case-study
 
DIABETES KETOACIDOSIS CASE PRESENTATION
DIABETES KETOACIDOSIS CASE PRESENTATIONDIABETES KETOACIDOSIS CASE PRESENTATION
DIABETES KETOACIDOSIS CASE PRESENTATION
 
Severe Acute Malnutrition
Severe Acute MalnutritionSevere Acute Malnutrition
Severe Acute Malnutrition
 
COPD & Nutrition
COPD & NutritionCOPD & Nutrition
COPD & Nutrition
 
Rrt
RrtRrt
Rrt
 
CeliacDiseaseCaseStudy_MNT
CeliacDiseaseCaseStudy_MNTCeliacDiseaseCaseStudy_MNT
CeliacDiseaseCaseStudy_MNT
 
Diabetes challenging cases
Diabetes challenging casesDiabetes challenging cases
Diabetes challenging cases
 
CS9CD_Gutierrez_Hill_Leslie_Marsh_Final
CS9CD_Gutierrez_Hill_Leslie_Marsh_FinalCS9CD_Gutierrez_Hill_Leslie_Marsh_Final
CS9CD_Gutierrez_Hill_Leslie_Marsh_Final
 
1.What is tpn and who needs it
1.What is tpn and who needs it1.What is tpn and who needs it
1.What is tpn and who needs it
 

En vedette

57765772 acute-renal-failure-case-study
57765772 acute-renal-failure-case-study57765772 acute-renal-failure-case-study
57765772 acute-renal-failure-case-studyhomeworkping3
 
Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...
Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...
Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...Prudhvi Krishna
 
Case study end of life - compassionate care
Case study end of life - compassionate careCase study end of life - compassionate care
Case study end of life - compassionate careMirjana Petravic
 
Renal Tubular Pigmentation Associated with Senna-Related Metabolites
Renal Tubular Pigmentation Associated with Senna-Related MetabolitesRenal Tubular Pigmentation Associated with Senna-Related Metabolites
Renal Tubular Pigmentation Associated with Senna-Related MetabolitesEPL, Inc.
 
PRCA post renal transplant-a case and review
PRCA post renal transplant-a case and reviewPRCA post renal transplant-a case and review
PRCA post renal transplant-a case and reviewVishal Golay
 
Mark Haas Kidney Summary Banff 2013 in Brazil
Mark Haas Kidney Summary Banff 2013 in Brazil Mark Haas Kidney Summary Banff 2013 in Brazil
Mark Haas Kidney Summary Banff 2013 in Brazil Kim Solez ,
 
Case Study - Adult - Hypotension - Renal Disease
Case Study - Adult - Hypotension - Renal DiseaseCase Study - Adult - Hypotension - Renal Disease
Case Study - Adult - Hypotension - Renal DiseaseUscom - Case Studies
 
Histopathological Kidney Honours Powerpoint
Histopathological Kidney Honours PowerpointHistopathological Kidney Honours Powerpoint
Histopathological Kidney Honours PowerpointEveFisher
 
Case Study Presentation-Rachael Joseph
Case Study Presentation-Rachael JosephCase Study Presentation-Rachael Joseph
Case Study Presentation-Rachael JosephRachael Joseph
 
Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...
Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...
Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...St John's Laboratory Ltd
 
C4d positivity in Renal transplant rejection
C4d positivity in Renal transplant rejectionC4d positivity in Renal transplant rejection
C4d positivity in Renal transplant rejectionimrana tanvir
 
Case based presentation(Chronic renal failure and Dialysis)
Case based presentation(Chronic renal failure and Dialysis)Case based presentation(Chronic renal failure and Dialysis)
Case based presentation(Chronic renal failure and Dialysis)Irum Khan
 

En vedette (18)

57765772 acute-renal-failure-case-study
57765772 acute-renal-failure-case-study57765772 acute-renal-failure-case-study
57765772 acute-renal-failure-case-study
 
Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...
Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...
Non‑diabetic renal disease in type 2 diabetes mellitus: Study of renal - reti...
 
A Case of Postpartum Renal Failure
A Case of Postpartum Renal FailureA Case of Postpartum Renal Failure
A Case of Postpartum Renal Failure
 
Case study end of life - compassionate care
Case study end of life - compassionate careCase study end of life - compassionate care
Case study end of life - compassionate care
 
Renal Tubular Pigmentation Associated with Senna-Related Metabolites
Renal Tubular Pigmentation Associated with Senna-Related MetabolitesRenal Tubular Pigmentation Associated with Senna-Related Metabolites
Renal Tubular Pigmentation Associated with Senna-Related Metabolites
 
PRCA post renal transplant-a case and review
PRCA post renal transplant-a case and reviewPRCA post renal transplant-a case and review
PRCA post renal transplant-a case and review
 
Mark Haas Kidney Summary Banff 2013 in Brazil
Mark Haas Kidney Summary Banff 2013 in Brazil Mark Haas Kidney Summary Banff 2013 in Brazil
Mark Haas Kidney Summary Banff 2013 in Brazil
 
Case Study - Adult - Hypotension - Renal Disease
Case Study - Adult - Hypotension - Renal DiseaseCase Study - Adult - Hypotension - Renal Disease
Case Study - Adult - Hypotension - Renal Disease
 
Histopathological Kidney Honours Powerpoint
Histopathological Kidney Honours PowerpointHistopathological Kidney Honours Powerpoint
Histopathological Kidney Honours Powerpoint
 
Case Study Presentation-Rachael Joseph
Case Study Presentation-Rachael JosephCase Study Presentation-Rachael Joseph
Case Study Presentation-Rachael Joseph
 
Renal Case Study
Renal Case StudyRenal Case Study
Renal Case Study
 
A Case of Renal Amyloidosis
A Case of Renal AmyloidosisA Case of Renal Amyloidosis
A Case of Renal Amyloidosis
 
CRRT options in the ICU
CRRT options in the ICUCRRT options in the ICU
CRRT options in the ICU
 
Use of algorithm in IHC
Use of algorithm in IHCUse of algorithm in IHC
Use of algorithm in IHC
 
Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...
Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...
Immunohistochemistry Antibody Validation Report for Anti-Phospho-JNK1/2/3 (T1...
 
C4d positivity in Renal transplant rejection
C4d positivity in Renal transplant rejectionC4d positivity in Renal transplant rejection
C4d positivity in Renal transplant rejection
 
Case based presentation(Chronic renal failure and Dialysis)
Case based presentation(Chronic renal failure and Dialysis)Case based presentation(Chronic renal failure and Dialysis)
Case based presentation(Chronic renal failure and Dialysis)
 
Case study: End stage renal failure
Case study: End stage renal failureCase study: End stage renal failure
Case study: End stage renal failure
 

Similaire à FSHN450HemodialysisRenalCalcCaseStudy

CDK case study pdf nov 13
CDK case study pdf nov 13CDK case study pdf nov 13
CDK case study pdf nov 13Carolina chaves
 
Nutritional management of renal diseases
Nutritional management of renal diseasesNutritional management of renal diseases
Nutritional management of renal diseasesWajid Rather
 
Nutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study ApproachNutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study Approachkiolinski
 
child_malnutrition_final_FINAL.pptx
child_malnutrition_final_FINAL.pptxchild_malnutrition_final_FINAL.pptx
child_malnutrition_final_FINAL.pptxAnkitSahu944117
 
ibdpresentation-140206191203-phpapp01.pdf
ibdpresentation-140206191203-phpapp01.pdfibdpresentation-140206191203-phpapp01.pdf
ibdpresentation-140206191203-phpapp01.pdfChristineMacGinnis1
 
Vitamin D intoxication
Vitamin D intoxicationVitamin D intoxication
Vitamin D intoxicationDr Jishnu KR
 
Nutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisNutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisManiz Joshi
 
Clinical Case Study EDW Emily Walker
Clinical Case Study EDW Emily WalkerClinical Case Study EDW Emily Walker
Clinical Case Study EDW Emily WalkerEmily Walker
 
Nutrition &amp; drug dosing in dialysis patient
Nutrition &amp; drug dosing  in dialysis patientNutrition &amp; drug dosing  in dialysis patient
Nutrition &amp; drug dosing in dialysis patientPabitra Thapa
 
Medical nutrition therapy status post whipple procedure
Medical nutrition therapy status post whipple procedureMedical nutrition therapy status post whipple procedure
Medical nutrition therapy status post whipple procedureValerie Agyeman
 

Similaire à FSHN450HemodialysisRenalCalcCaseStudy (20)

CKD Case Study
CKD Case StudyCKD Case Study
CKD Case Study
 
CKD case studyyyy
CKD case studyyyyCKD case studyyyy
CKD case studyyyy
 
CDK case study pdf nov 13
CDK case study pdf nov 13CDK case study pdf nov 13
CDK case study pdf nov 13
 
Nutritional management of renal diseases
Nutritional management of renal diseasesNutritional management of renal diseases
Nutritional management of renal diseases
 
Renal Disorders & MNT.ppt
Renal Disorders & MNT.pptRenal Disorders & MNT.ppt
Renal Disorders & MNT.ppt
 
Nutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study ApproachNutrition Therapy For CKD: A Case Study Approach
Nutrition Therapy For CKD: A Case Study Approach
 
carbo case reports.pptx
carbo case reports.pptxcarbo case reports.pptx
carbo case reports.pptx
 
child_malnutrition_final_FINAL.pptx
child_malnutrition_final_FINAL.pptxchild_malnutrition_final_FINAL.pptx
child_malnutrition_final_FINAL.pptx
 
Case presentation
Case presentationCase presentation
Case presentation
 
ibdpresentation-140206191203-phpapp01.pdf
ibdpresentation-140206191203-phpapp01.pdfibdpresentation-140206191203-phpapp01.pdf
ibdpresentation-140206191203-phpapp01.pdf
 
Vitamin D intoxication
Vitamin D intoxicationVitamin D intoxication
Vitamin D intoxication
 
Nutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisNutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysis
 
Clinical Case Study EDW Emily Walker
Clinical Case Study EDW Emily WalkerClinical Case Study EDW Emily Walker
Clinical Case Study EDW Emily Walker
 
Nutrition &amp; drug dosing in dialysis patient
Nutrition &amp; drug dosing  in dialysis patientNutrition &amp; drug dosing  in dialysis patient
Nutrition &amp; drug dosing in dialysis patient
 
Parenteral nutrition copy
Parenteral nutrition   copyParenteral nutrition   copy
Parenteral nutrition copy
 
Tpn 7e
Tpn 7eTpn 7e
Tpn 7e
 
Ckd mbd mih
Ckd mbd mihCkd mbd mih
Ckd mbd mih
 
Medical nutrition therapy status post whipple procedure
Medical nutrition therapy status post whipple procedureMedical nutrition therapy status post whipple procedure
Medical nutrition therapy status post whipple procedure
 
Pediatric DKA.pptx
Pediatric DKA.pptxPediatric DKA.pptx
Pediatric DKA.pptx
 
Hypokalemia
HypokalemiaHypokalemia
Hypokalemia
 

Plus de Anna King

AKingFSHN386journal
AKingFSHN386journalAKingFSHN386journal
AKingFSHN386journalAnna King
 
FSHN450LiverDiseaseGERDCaseStudy
FSHN450LiverDiseaseGERDCaseStudyFSHN450LiverDiseaseGERDCaseStudy
FSHN450LiverDiseaseGERDCaseStudyAnna King
 
FSHN496BConsciousEatingpaper
FSHN496BConsciousEatingpaperFSHN496BConsciousEatingpaper
FSHN496BConsciousEatingpaperAnna King
 
CheesePaperRRM311-001Spring2015
CheesePaperRRM311-001Spring2015CheesePaperRRM311-001Spring2015
CheesePaperRRM311-001Spring2015Anna King
 
FSHN450IBMCaseStudy
FSHN450IBMCaseStudyFSHN450IBMCaseStudy
FSHN450IBMCaseStudyAnna King
 
FSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudyFSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudyAnna King
 

Plus de Anna King (6)

AKingFSHN386journal
AKingFSHN386journalAKingFSHN386journal
AKingFSHN386journal
 
FSHN450LiverDiseaseGERDCaseStudy
FSHN450LiverDiseaseGERDCaseStudyFSHN450LiverDiseaseGERDCaseStudy
FSHN450LiverDiseaseGERDCaseStudy
 
FSHN496BConsciousEatingpaper
FSHN496BConsciousEatingpaperFSHN496BConsciousEatingpaper
FSHN496BConsciousEatingpaper
 
CheesePaperRRM311-001Spring2015
CheesePaperRRM311-001Spring2015CheesePaperRRM311-001Spring2015
CheesePaperRRM311-001Spring2015
 
FSHN450IBMCaseStudy
FSHN450IBMCaseStudyFSHN450IBMCaseStudy
FSHN450IBMCaseStudy
 
FSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudyFSHN450DiabetesCaseStudy
FSHN450DiabetesCaseStudy
 

FSHN450HemodialysisRenalCalcCaseStudy

  • 1. 1 Anna King CSU ID# 829672579 FSHN 450; Fall Semester 2014 Case Study VI: Hemodialysis & Renal Diet Calculation November 5, 2014 I have not given, received, or used any unauthorized assistance on this assignment. Anna King 11/5/2014
  • 2. 2 In table format, evaluate the patient’s laboratory data compared to goals for dialysis patients. Value Patient’s Value Dialysis patient Goal Sodium 135 mEq/L 135-145 mEq/L Potassium 4.4 mEq/L 3.5-5.5 mEq/L Chloride 111 mEq/L 100-110mEq/L CO 2 15 mEq/L 22-25 mEq/L Calcium 7.5 mg/dl 8.5-10.5 mg/dl Phos 10.2 mg/dl 3-6 mg/dl BUN 108 mg/dl 50-100 mg/dl Creatinine 14.0 mg/dl >15 mg/dl Albumin 2.8 g/dl 3.5-5 g/dl Hemoglobin 8.3 g/dl 7.4-9.9 g/dl Hct 24.3% 35-47% Transferrin Sat 18% 15-50% MCV 70 fl 80-99 fl WBC 8.7 X 109 /L 5-10 x 109 /L Urine protein 320 mg/24 hr 3-6 g/24 hr What is the purpose of each medication which has been prescribed for the patient? List drug:nutrient (food:medication) interactions for each. Lasix: increases excretion of sodium, potassium, magnesium, and calcium in urine- natural licorice may counteract the drug; maintain diet high in these compounds (may need supplementation) Lisinopril: ACE inhibitor, increases serum potassium levels-monitor hydration and fluid intake as well as salt and potassium intake (may be sensitive to potassium levels)
  • 3. 3 Metoprolol: 𝛽-Adrenergic antagonist masks sympathetic signs of hypoglycemia-may decrease insulin release (in response to hypoglycemia), watch BG levels Renvela: phosphate binder (controls phosphate levels)- be careful with calcium supplements to prevent secondary hyperparathyroidism Zemplar: helps absorb calcium and helps with secondary hyperthyroidism- problems if allergic to man-made vitamin D or if there are high levels of calcium in the blood EPO: attends to anemia in patients- monitor iron status in patient! Ferrlecit: helps with anemia- may cause hypotension, excessive iron, and benzyl alcohol toxicity What is secondary hyperparathyroidism and why is this patient at risk? What are the consequences and how is this managed medically? Nutritionally? Secondary hyperthyroidism is a result of kidney malfunction/failure. When the patient’s kidney cannot filter minerals (in the case of secondary hyperparathyroidism, calcium and phosphorous, specifically) out of the blood properly, their levels shoot out of proportion. Generally, in the body, low levels of phosphorous and calcium in the blood are ideal. In secondary hyperparathyroidism, serum calcium levels are low while serum phosphorous increases; this triggers the parathyroid hormone to increase, which then, in turn, increases reabsorption of calcium. Since calcium levels are already low, the body takes calcium from bones of the body; this also mobilizes phosphorous from the bone. Increased levels of calcium and phosphorous from the bone, now in the bloodstream don’t necessarily have anywhere to go, so they form crystals in the tissues of the body. The patient is at risk of secondary hyperparathyroidism because she is in Stage 5 (the final stage) of chronic kidney failure. This is irreversible and she has to depend on dialysis for the rest of her life. Since her kidney cannot filter minerals properly, she is definitively at risk for secondary hyperparathyroidism. This condition is managed medically by frequent hemodialysis and is managed nutritionally by controlling intake of calcium and phosphorous. Assess the patient’s Kcal, protein, Phos, K, Na, and fluid intake recommendations. Kcal: 2061 kcal (35 kcal/Kg IBW) IBW=105+(5 x 5)=130lbs=58.9Kg
  • 4. 4 Protein: 71g (1.2 g/Kg IBW) Phos: 0.8-1.2 g/day K: 2-3 g/day Na: 2-3 g/day Fluid: 750 ml (750-1000 ml/day urine output) Evaluate the patient’s current dietary intake including the following points: How does CN’s current intake compare to these recommendations? Some of the patient’s food is high in phosphorous, which she should monitor more closely. Although adequate calcium intake is required, she should be more careful when consuming foods. Calculate a dietary pattern which would meet the recommendations for this patient and using foods create a sample one day diet. Use table format and the handouts provided in class. This part counts as your renal diet calculation in addition to your case study. Protein: 17% of Kcal= 350 Kcal Fat: <30% of Kcal= 618 Kcal Carbohydrate: 53% of Kcal= 1092 Kcal Carb Protein Fat Na (mg) K (mg) P (mg) 1 cup milk 6 4 - 60 190 115 Fruit- Low K: pineapple (½ cup) 15 - - 15 100 15 Fruit- Med K: apple (1) 15 - - 15 200 15 Fruit- High K: kiwi (1) 15 - - 15 350 15 Veg- Low K: corn (½ cup) 5 2 - 15 100 20 Veg- Med K: peppers (1) 5 2 - 15 200 20 Veg- High K: sweet yam (½ cup) 5 2 - 15 350 20 Bread 209 17.5 40 35 500 450 SF Meat - 60 29 75 75 65 Reg Fat - - - 10 10 5
  • 5. 5 Totals: 1100+350+621=2061 Kcal/day (275x4) = 1100 (87.5x4) = 350 (69x9 )=621 270 2075 740 Write two PES statements - one in the clinical and one in the behavioral domain and provide an intervention, monitoring, and evaluation plan for each. (1) Altered GI function [NC-1.4] related to abnormal absorption of calcium and phosphorous as evidence by kidney failure and hemodialysis. (2) Self monitoring deficit [NB-1.4] related to insufficient diet as evidence by 24 hour dietary intake log and medication needs. Intervention: (1) Take prescribed medications, monitor dietary choices (maintain low potassium and phosphorous levels in diet). (2) Watch diet! Educate patient on what to eat and what to avoid (avoid nuts and legumes, eat plenty of fruits and vegetables!) and show her how her diet and the foods she chooses affect her body physically. Monitoring/Evaluation: (1) Watch lab results on all values listed above, test urine samples to keep patient on track; hemodialysis every 2-3 days; monitor GI functioning. (2) . Monitor medication intake and make sure dosages and utilizations are correct.